Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M166Revenue $M33.0Net Margin (%)-13.4Z-Score-7.0
Enterprise Value $M144EPS $-0.7Operating Margin %6.4F-Score3
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-13.4Higher ROA y-yN
Price/Book61.010-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %-67.5Current Ratio1.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-5.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-38.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M140ROI % (ttm)-164.8Gross Margin Increase y-yN

Gurus Latest Trades with ZGNX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ZGNX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ZGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARNER CAM LDirector 2014-06-13Buy30,000$1.66-26.51 view
FARR STEPHEN JPresident and COO 2014-06-03Sell20,900$2.1-41.9 view
HAWLEY ROGERCEO 2014-06-03Sell25,078$2.1-41.9 view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2014-06-03Sell19,229$2.1-41.9 view
Shively Richard ScottChief Commercial Officer 2014-06-03Sell19,229$2.1-41.9 view
Shively Richard ScottChief Commercial Officer 2013-11-20Buy67,000$2.79-56.27 view
Robinson Cynthia YChief Development Officer 2012-12-13Buy50,000$1.174.27 view
GARNER CAM LDirector 2012-12-12Buy70,000$1.210.83 view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2012-12-12Buy17,500$1.192.52 view
MAST ERLE TDirector 2012-12-11Buy10,000$1.156.09 view

Press Releases about ZGNX :

    Quarterly/Annual Reports about ZGNX:

    News about ZGNX:

    Articles On GuruFocus.com
    comment on ZGNX Mar 23 2013 
    Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB Dec 24 2012 
    (ZGNX) CEO Roger Hawley buys 10,000 Shares Dec 06 2010 

    More From Other Websites
    ZOGENIX, INC. Files SEC form 8-K, Other Events Oct 01 2014
    8:33 am Zogenix announced it submitted sNDA for a modified formulation of Zohydro ER Oct 01 2014
    Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for... Oct 01 2014
    ZOGENIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 19 2014
    ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 18 2014
    New Data Shows Zohydro(R) ER Reduced Pain and Improved Function in People With Chronic Pain Sep 18 2014
    ZOGENIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Sep 08 2014
    ZOGENIX, INC. Files SEC form 8-K, Other Events Sep 04 2014
    Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse,... Sep 04 2014
    Zogenix to Participate in Morgan Stanley Global Healthcare Conference 2014 Sep 02 2014
    Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief Sep 02 2014
    ZOGENIX, INC. Financials Aug 19 2014
    ZOGENIX, INC. Files SEC form 8-K, Other Events Aug 14 2014
    Does Zogenix Need a Painkiller? A Drug Maker Struggles With Controversy Aug 07 2014
    ZOGENIX, INC. Files SEC form 10-Q, Quarterly Report Aug 06 2014
    Zogenix Inc Earnings Call scheduled for 4:30 pm ET today Aug 05 2014
    ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 05 2014
    Zogenix Reports Second Quarter 2014 Financial Results Aug 05 2014
    Q2 2014 Zogenix, Inc. Earnings Release - After Market Close Aug 05 2014
    Express Scripts drops Amgen anemia drugs from formulary Aug 01 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK